Skip to search formSkip to main contentSkip to account menu

ULBP2 gene

Known as: UL16-BINDING PROTEIN 2, RAET1H, UL16 Binding Protein 2 Gene 
This gene plays a role in the function of natural killer cells.
National Institutes of Health

Related topics

Related topics

3 relations
NKG2D Ligand 2ULBP2 protein, human

Narrower (1)

ULBP2 wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Unraveling the expression of microRNA‐27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients
The activity of natural killer (NK) cells is known to be decreased in systemic lupus erythematosus (SLE) patients. Nevertheless… 
2017
2017
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
Natural killer cells (NK) are essential for the elimination of resistant acute myeloid and acute lymphoblastic leukemia (AML and… 
2015
2015
Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.
PURPOSE The study aimed to investigate the role of the JAK/STAT3 pathway in the matrine induced ULBP2 expression on the human… 
2013
2013
Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment.
2012
2012
Plasma levels of soluble MICA and ULBP2 are increased in children allergic to dust mites.
2011
2011
Overexpression of IL-32α Increases Natural Killer Cell-mediated Killing through Up-regulation of Fas and UL16-binding protein 2 (ULBP2) Expression in Human Chronic Myeloid Leukemia Cells*
IL-32 was recently identified as a proinflammatory cytokine that is induced by IL-18 in natural killer (NK) cells and is highly… 
2011
2011
Induction of In Vitro and In Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
Cancer that might develop as host natural killer (NK) cells fail to detect ligands for their activating NK receptors… 
2008
2008
IL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells.
Highly Cited
2007
Highly Cited
2007
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection.
Monocyte-derived dendritic cells (mDCs) and NK cells are reciprocally activate via cytokines and cell-cell contact. Although… 
Highly Cited
2002
Highly Cited
2002
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia…
PURPOSE The purpose of the study is to investigate the tolerability of interleukin 2 (IL-2) after intensive chemotherapy in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)